The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study
|
---|---|
Published in |
Frontiers in immunology, August 2023
|
DOI | 10.3389/fimmu.2023.1228461 |
Pubmed ID | |
Authors |
Amir I. Tukhvatulin, Inna V. Dolzhikova, Alina S. Dzharullaeva, Daria M. Grousova, Anna V. Kovyrshina, Olga V. Zubkova, Ilya D. Zorkov, Anna A. Iliukhina, Artem Y. Shelkov, Alina S. Erokhova, Olga Popova, Tatiana A. Ozharovskaia, Denis I. Zrelkin, Fatima M. Izhaeva, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Elisaveta A. Tokarskaya, Natalia A. Nikitenko, Nadezhda L. Lubenets, Elizaveta A. Khadorich, Vladimir A. Gushchin, Svetlana N. Borzakova, Anna V. Vlasova, Ismail M. Osmanov, Valerii V. Gorev, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 20 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 15% |
Lecturer | 2 | 10% |
Researcher | 2 | 10% |
Professor | 1 | 5% |
Student > Doctoral Student | 1 | 5% |
Other | 0 | 0% |
Unknown | 11 | 55% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 3 | 15% |
Nursing and Health Professions | 2 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Social Sciences | 1 | 5% |
Engineering | 1 | 5% |
Other | 0 | 0% |
Unknown | 12 | 60% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2023.
All research outputs
#8,996,818
of 26,510,312 outputs
Outputs from Frontiers in immunology
#11,544
of 33,346 outputs
Outputs of similar age
#133,850
of 369,685 outputs
Outputs of similar age from Frontiers in immunology
#301
of 1,213 outputs
Altmetric has tracked 26,510,312 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,346 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,685 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 1,213 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.